Compounds > xamoterol
Page last updated: 2024-09-04

xamoterol and alvocidib

xamoterol has been researched along with alvocidib in 1 studies

Compound Research Comparison

Studies
(xamoterol)		Trials
(xamoterol)		Recent Studies (post-2010)
(xamoterol)		Studies
(alvocidib)		Trials
(alvocidib)		Recent Studies (post-2010) (alvocidib)
269801762766204

Protein Interaction Comparison

ProteinTaxonomyxamoterol (IC50)alvocidib (IC50)
Chain A, Protein (glycogen Phosphorylase)Oryctolagus cuniculus (rabbit)1
Glycogen synthase kinase-3 beta Sus scrofa (pig)0.36
[Tau protein] kinase Sus scrofa (pig)0.36
Cyclin-T1Homo sapiens (human)0.0243
Cyclin-KHomo sapiens (human)1.37
Serine/threonine-protein kinase D3Homo sapiens (human)8
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.1571
G1/S-specific cyclin-E2Homo sapiens (human)0.36
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)1.2
Epidermal growth factor receptorHomo sapiens (human)7.6
Vitamin K-dependent protein CHomo sapiens (human)0.1429
Protein kinase C gamma typeHomo sapiens (human)8
Protein kinase C beta typeHomo sapiens (human)8
Tyrosine-protein kinase LckHomo sapiens (human)0.4
Cyclin-dependent kinase 1Homo sapiens (human)0.1159
Cyclin-dependent kinase 4Homo sapiens (human)0.1589
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.1464
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.2067
Protein kinase C alpha typeHomo sapiens (human)6.2667
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.185
Cyclin-A2Homo sapiens (human)0.3441
Dual specificity protein kinase CLK1Mus musculus (house mouse)1.3
G1/S-specific cyclin-D1Homo sapiens (human)0.1837
Protein kinase C eta typeHomo sapiens (human)8
G1/S-specific cyclin-E1Homo sapiens (human)0.2249
Cyclin-dependent kinase 2Homo sapiens (human)0.2367
G1/S-specific cyclin-D2Homo sapiens (human)0.1
G1/S-specific cyclin-D3Homo sapiens (human)0.1983
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.4
Protein kinase C iota typeHomo sapiens (human)8
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.525
Glycogen synthase kinase-3 betaHomo sapiens (human)0.6517
Cyclin-dependent kinase 7Homo sapiens (human)0.3365
Cyclin-dependent kinase 9Homo sapiens (human)0.0209
Cyclin-HHomo sapiens (human)0.3413
CDK-activating kinase assembly factor MAT1Homo sapiens (human)0.514
Cyclin-A1Homo sapiens (human)0.785
Cyclin-dependent kinase 6Homo sapiens (human)0.1572
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.1747
Cyclin homologHerpesvirus saimiri (strain 11)0.185
Protein kinase C epsilon typeHomo sapiens (human)5.4933
Protein kinase C theta typeHomo sapiens (human)8
Protein kinase C zeta typeHomo sapiens (human)8
Protein kinase C delta typeHomo sapiens (human)5.63
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.1765
Serine/threonine-protein kinase D1Homo sapiens (human)8
Dual specificity tyrosine-phosphorylation-regulated kinase 1ARattus norvegicus (Norway rat)0.3
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.1571
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.2067
Cyclin-dependent kinase 12Homo sapiens (human)1.37

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1

Other Studies

1 other study(ies) available for xamoterol and alvocidib

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008